Personal tools

MCL coexpression mm9:2959: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0002346!3.23e-28!64;UBERON:0003075!3.23e-28!64;UBERON:0007284!3.23e-28!64;UBERON:0001017!6.19e-27!73;UBERON:0001016!1.21e-26!75;UBERON:0000073!9.45e-26!54;UBERON:0004121!1.54e-24!95;UBERON:0000924!1.54e-24!95;UBERON:0006601!1.54e-24!95;UBERON:0001049!3.56e-24!52;UBERON:0005068!3.56e-24!52;UBERON:0006241!3.56e-24!52;UBERON:0007135!3.56e-24!52;UBERON:0003056!3.60e-23!49;UBERON:0010371!3.63e-23!73;UBERON:0000955!1.65e-20!47;UBERON:0006238!1.65e-20!47;UBERON:0002616!8.07e-20!46;UBERON:0003080!2.44e-18!40;UBERON:0002780!1.03e-17!39;UBERON:0001890!1.03e-17!39;UBERON:0006240!1.03e-17!39;UBERON:0002020!2.82e-17!34;UBERON:0010314!1.40e-15!92;UBERON:0003528!9.70e-14!29;UBERON:0002791!9.70e-14!29;UBERON:0001893!9.70e-14!29;UBERON:0000956!9.05e-09!21;UBERON:0001869!9.05e-09!21;UBERON:0000203!9.05e-09!21;UBERON:0002619!4.86e-08!17
|ontology_enrichment_uberon=UBERON:0002346!3.23e-28!64;UBERON:0003075!3.23e-28!64;UBERON:0007284!3.23e-28!64;UBERON:0001017!6.19e-27!73;UBERON:0001016!1.21e-26!75;UBERON:0000073!9.45e-26!54;UBERON:0004121!1.54e-24!95;UBERON:0000924!1.54e-24!95;UBERON:0006601!1.54e-24!95;UBERON:0001049!3.56e-24!52;UBERON:0005068!3.56e-24!52;UBERON:0006241!3.56e-24!52;UBERON:0007135!3.56e-24!52;UBERON:0003056!3.60e-23!49;UBERON:0010371!3.63e-23!73;UBERON:0000955!1.65e-20!47;UBERON:0006238!1.65e-20!47;UBERON:0002616!8.07e-20!46;UBERON:0003080!2.44e-18!40;UBERON:0002780!1.03e-17!39;UBERON:0001890!1.03e-17!39;UBERON:0006240!1.03e-17!39;UBERON:0002020!2.82e-17!34;UBERON:0010314!1.40e-15!92;UBERON:0003528!9.70e-14!29;UBERON:0002791!9.70e-14!29;UBERON:0001893!9.70e-14!29;UBERON:0000956!9.05e-09!21;UBERON:0001869!9.05e-09!21;UBERON:0000203!9.05e-09!21;UBERON:0002619!4.86e-08!17
|tfbs_overrepresentation_for_novel_motifs=0.752782,0.193418,0.722405,0.801166,0.587814,0.81763,0.919454,0.467321,0.479531,0.66329,0.870507,0.906098,0.467629,0.933025,0.608226,0,1.14208,0.578045,0.448066,0.328717,0.679146,0.275782,0.932027,0.585919,0.731217,0.963352,0.437236,0.841386,0.64294,0.380786,0.825437,1.24901,0.575271,1.05917,1.47967,0.872889,2.37023,0.902078,0.536514,1.24975,0.582863,0.831295,0.261619,0.610669,0.922882,0.788421,1.05665,0.859154,0.235354,0.646474,1.12346,0.99279,0.371606,1.3966,1.41464,0.940919,0.657156,0.891887,0.425455,0.938668,1.22795,1.00308,0.494668,1.11142,0.953187,1.15459,1.55483,1.90983,1.22303,1.7608,0.700291,0.474956,2.1742,1.44925,1.882,1.83166,0.411601,1.04436,1.20986,0.684144,0.476502,1.16055,1.00151,0.459035,1.32978,8.73829,1.69956,0.380977,1.06194,2.07346,1.62608,1.33496,1.26245,0.595071,1.31639,0.509215,0.464141,1.26539,1.05692,0.928366,0.563856,1.24872,1.37854,1.12409,1.12297,0.830796,1.18646,0.854628,0.689894,1.63106,0.744607,1.38039,0.685481,0.876299,1.63327,0.580657,1.79445,0.805461,1.14346,0.559153,1.45481,1.08896,0.965352,1.04338,1.68841,1.21376,0.928483,1.25534,1.55328,0.598722,1.36093,0.792832,1.52297,0.955954,1.65529,0.273451,0.762499,0.832891,1.60513,2.44352,2.04137,1.55966,0.978551,1.26,1.11604,0.831808,1.06002,2.40374,0.765221,2.45536,0.38417,4.69532,1.39822,1.28513,0.954936,1.48249,0.993889,0.622823,0.749933,0.762177,1.61484,1.32889,1.21423,0.741984,1.11251,0.94678,0.562367,0.904334,1.95046
}}
}}

Revision as of 22:12, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr15:103333594..103333648,+p2@Pde1b
Mm9::chr7:108043087..108043098,-p8@Arhgef17
Mm9::chr8:121970938..121971035,+p1@Necab2


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0017000antibiotic biosynthetic process0.0153365824918586
GO:0016999antibiotic metabolic process0.0153365824918586
GO:0017144drug metabolic process0.0153365824918586
GO:0007632visual behavior0.0341393564777385
GO:0008542visual learning0.0341393564777385
GO:00041143',5'-cyclic-nucleotide phosphodiesterase activity0.0341393564777385
GO:0004112cyclic-nucleotide phosphodiesterase activity0.0341393564777385
GO:0007612learning0.047803038389033
GO:0005089Rho guanyl-nucleotide exchange factor activity0.047803038389033
GO:0035023regulation of Rho protein signal transduction0.047803038389033
GO:0005088Ras guanyl-nucleotide exchange factor activity0.047803038389033
GO:0008081phosphoric diester hydrolase activity0.047803038389033
GO:0007611learning and/or memory0.047803038389033
GO:0009416response to light stimulus0.047803038389033
GO:0007266Rho protein signal transduction0.0488756573929596



Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Cell Type
Ontology termp-valuen
CNS neuron (sensu Vertebrata)2.44e-1323
neuroblast (sensu Vertebrata)2.44e-1323
ectodermal cell1.10e-1044
neurectodermal cell1.10e-1044
neural cell1.20e-1043
neuron1.55e-1033
neuronal stem cell1.55e-1033
neuroblast1.55e-1033
electrically signaling cell1.55e-1033
non-terminally differentiated cell5.79e-0749

Uber Anatomy
Ontology termp-valuen
neurectoderm3.23e-2864
neural plate3.23e-2864
presumptive neural plate3.23e-2864
central nervous system6.19e-2773
nervous system1.21e-2675
regional part of nervous system9.45e-2654
ectoderm-derived structure1.54e-2495
ectoderm1.54e-2495
presumptive ectoderm1.54e-2495
neural tube3.56e-2452
neural rod3.56e-2452
future spinal cord3.56e-2452
neural keel3.56e-2452
pre-chordal neural plate3.60e-2349
ecto-epithelium3.63e-2373
brain1.65e-2047
future brain1.65e-2047
regional part of brain8.07e-2046
anterior neural tube2.44e-1840
regional part of forebrain1.03e-1739
forebrain1.03e-1739
future forebrain1.03e-1739
gray matter2.82e-1734
structure with developmental contribution from neural crest1.40e-1592
brain grey matter9.70e-1429
regional part of telencephalon9.70e-1429
telencephalon9.70e-1429
cerebral cortex9.05e-0921
cerebral hemisphere9.05e-0921
pallium9.05e-0921
regional part of cerebral cortex4.86e-0817


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}